Molecular Health

Molecular Health is a leader in the hybridization of medicine, dedicated to building software solutions that empower healthcare professionals, clinical laboratories, and therapy developers with the latest advances in artificial intelligence and data-driven technology. By combining human expertise with cutting-edge data curation and deep analytics, Molecular Health connects and scales the world's biomedical knowledge, transforming it into actionable insights that deliver better patient outcomes.

The company serves two primary audiences: healthcare providers and clinical laboratories seeking genome-based therapy planning support, and pharmaceutical and biotech professionals looking to create value in drug development. Molecular Health's mission centers on making knowledge usable, delivering transparent and intuitive solutions that are evidence-based, data-driven, and action-ready.

Key Products and Solutions

• MH Guide: A clinical decision support solution designed for healthcare providers and clinical laboratories. MH Guide leverages advanced analytics to guide genome-based, personalized therapy planning. A dedicated Customer Success Team of application specialists supports partners in using MH Guide to its fullest potential.
• Dataome Technology: A proprietary technology platform that integrates and standardizes massive datasets from numerous sources into a unified resource called Dataome. It underpins advanced analyses for AI-enabled drug development and supports pharmaceutical and biotech professionals in overcoming key hurdles in the drug development process.
• AI Pharma Solutions: Dedicated data-driven analyses built on Dataome Technology, designed to support AI-guided drug development workflows for pharmaceutical and biotech customers.

Core Capabilities

• Biomedical data curation: Professional biomedical data curators continuously monitor the state of biomedical knowledge, covering real-world data, molecular findings, genomic insights, and recommendations from regulatory authorities and drug approval bodies, ensuring solutions remain current, reliable, and relevant.
• Data integration and management: Database experts vet, organize, structure, and connect large-scale datasets that are wrangled, standardized, and integrated from numerous sources into the Dataome platform.
• Advanced analytics: Analytics experts engineer the analysis functions within MH Guide and the dedicated analytical strategies for AI Pharma Solutions. All analytical strategies are documented and traceable, enabling customers to rely on the solutions with confidence.
• Human expertise at scale: Highly skilled subject matter experts ensure that all solutions provide clean, relevant, high-quality data and top analytical performance to guide personalized therapy decisions.

Company Values and Approach

• Patient focus: All work aims to improve the quality and speed of treatment and care options for patients.
• Usable results: A transparent, intuitive, and informative user experience is central to every solution.
• Innovation: Solutions continuously evolve to meet current healthcare needs and recommendations.
• Diversity: Teams tackle challenges with diverse ideas, strengths, and backgrounds.

Leadership

• Friedrich von Bohlen und Halbach, PhD – Chief Executive Officer: Co-founder of Molecular Health with over 25 years of entrepreneurial experience in the industry. He holds a diploma in biochemistry from the University of Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology, Zurich, and serves as chairman or board member of several national and international biotech companies and organizations.
• Stephan Brock, PhD – Chief Technology Officer: Co-founder of Molecular Health with extensive experience in bioinformatics, data integration analytics, artificial intelligence, text-data mining, and content management for the pharmaceutical industry. He has led large-scale bioinformatics projects supporting pharma R&D and IT infrastructure for integrative clinical trial data management at cancer centers. He holds a PhD in biochemistry from the University of Bayreuth.
• Burkard Piper – Member of the Executive Team.
• Matthias Kopf, PhD – SVP, Head of Business Unit Molecular Analysis Solutions: Took over leadership of the Business Unit Molecular Analysis Solutions in 2023 after serving as Head of Product Management for five years, overseeing product management, customer success, medical affairs, marketing, and sales activities, with a background in molecular biology and bioinformatics.

Molecular Health combines powerful software tools with a dedicated team of experts — including subject matter specialists, data curators, database engineers, analytics professionals, and customer success managers — to provide partners with cutting-edge, evidence-based insights that support meaningful decisions in both clinical care and drug development.